[Clinical experience with 17-beta-hydroxy-17-alpha-methyl-2-oxa-5-alpha-androstan-3-one (oxandrolone)].
D000293:Adolescent; D000328:Adult; D000856:Anorexia Nervosa / Q000188:drug therapy*; D001835:Body Weight / Q000187:drug effects; D002543:Cerebral Hemorrhage / Q000188:drug therapy*; D005260:Female; D006801:Humans; D002542:Intracranial Embolism and Thrombosis / Q000188:drug therapy*; D008297:Male; D010074:Oxandrolone / Q000009:adverse effects / Q000627:therapeutic use*; D013272:Stomach Diseases / Q000188:drug therapy*; D013607:Tablets; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D013607:Tablets; D010074:Oxandrolone